A year ago, on August 14, 2024, the World Health Organization declared mpox a Public Health Emergency of International ...

WHO DG cautioned that drastic reductions in foreign assistance are now hampering access to key public health interventions.

In justifying the United States' rejection of updates to global health regulations, the Department of Health and Human Services and Secretary Robert F. Kennedy Jr. falsely claimed that the policy ...

The World Health Organization (WHO) announced that it will continue to classify mpox (monkeypox) as a Public Health Emergency of International Concern (PHEIC) due to a continuous rise in cases ...

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee ...

This will be a randomized clinical trial comparing NV-387 treatment with the Standard of Care, to evaluate the dosing regimen for NV-387, the safety and tolerability of the dosing regimen in MPox ...

The World Health Organization on Wednesday declared mpox a global public health emergency for the second time in two years, ...

Spread This News By Staff Reporter  THE Ministry of Health and Child Care has warned the public to be on high alert over the ...

The World Health Organisation (WHO) has reiterated that Mpox -- formerly known as monkeypox -- remains a Public Health Emergency of International Concern (PHEIC), as the virus continues to resurface ...

While vaccination has started, overall, the uptake of available vaccines has remained lower than anticipated due to logistical, operational, and financial barriers, according to the report of the ...

This will be a randomized clinical trial comparing NV-387 treatment with the Standard of Care, to evaluate the dosing regimen for NV-387, the safety and tolerability of the dosing regimen in MPox ...

This will be a randomized clinical trial comparing NV-387 treatment with the Standard of Care, to evaluate the dosing regimen for NV-387, the safety and tolerability of the dosing regimen in MPox ...